In this article, a novel hybridized Multi-Attribute Decision Model (MADM) is developed to identify an optimal design of a Reconfigurable Assembly Fixture (RAF) from a set of alternative design concepts. The model combines the comparative advantage of Fuzzy Analytic Hierarchy Process (FAHP) and the computational strength of the Fuzzy Weighted Average (FWA) based on left and right scores in order to obtain aggregates for the design alternatives considering the relative importance of the design criteria as needed in the optimal design. The model was applied to evaluate four design concepts of a RAF with six design features having numerous sub-features. Results obtained from the evaluation process shows that there are differences in final values of the design alternatives. However, a close variation exists between these values. These differences can be accrued to the interrelationships between the design features and sub-features obtained from the Fuzzy Synthetic Extent (FSE) of the FAHP and an unambiguity judgment of the FWA when aggregating availability of the design features and sub-features in the design alternatives.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992994PMC
http://dx.doi.org/10.1016/j.heliyon.2020.e03182DOI Listing

Publication Analysis

Top Keywords

design
12
optimal design
12
design alternatives
12
design features
12
fuzzy analytic
8
analytic hierarchy
8
hierarchy process
8
fuzzy weighted
8
weighted average
8
design concepts
8

Similar Publications

Introduction: Although there are numerous options for epilepsy treatment, its effective control continues unsatisfactory. Thus, search for alternative therapeutic options to improve the efficacy/safety binomial of drugs becomes very attractive to investigate. In this context, intranasal administration of antiseizure drugs formulated on state-of-the-art nanosystems can be a promising strategy.

View Article and Find Full Text PDF

Background: This study aimed to provide a comprehensive review of adverse events (AEs) associated with factor Xa (FXa) inhibitors in pediatric patients.

Methods: We searched PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and the European Union Clinical Trials Register for English-language records from the establishment of the database up to October 17, 2023.

View Article and Find Full Text PDF

Purpose: To assess the efficacy and safety of PreserFlo MicroShunt (PMS) combined with mitomycin C in patients with medically treated primary open-angle glaucoma (POAG).

Study Design: A retrospective observational study.

Methods: The study examined 83 eyes from 83 patients with medically treated glaucoma surgery naive POAG.

View Article and Find Full Text PDF

Retinal detachment after acute retinal necrosis: a retrospective analysis of hospitalized patients.

Jpn J Ophthalmol

January 2025

Department of Visual Science and Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Purpose: To review hospitalized patients with Acute Retinal Necrosis (ARN) and investigate factors associated with subsequent retinal detachment (RD).

Study Design: Retrospective.

Methods: The study included 40 patients (42 eyes), categorized into non-RD (23 eyes) and RD (19 eyes) groups.

View Article and Find Full Text PDF

Visualization of porcine and human aqueous humor outflow tract anatomies with transparency enhancement.

Jpn J Ophthalmol

January 2025

Institute for Photon Science and Technology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan.

Purpose: There is no established method for visualizing the three-dimensional (3D) structure of the aqueous humor outflow tract. This study attempted to visualize the 3D structures of porcine and human ocular tissues, particularly the aqueous humor outflow tract using a transparency reagent composed of 2, 2-thiodiethanol.

Study Design: Clinical and experimental.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!